Journal article
Trans Fatty Acid Biomarkers and Incident Type 2 Diabetes: Pooled Analysis of 12 Prospective Cohort Studies in the Fatty Acids and Outcomes Research Consortium (FORCE)
Diabetes care, Vol.45(4), pp.854-863
04/01/2022
DOI: 10.2337/dc21-1756
PMCID: PMC9114723
PMID: 35142845
Abstract
Trans fatty acids (TFAs) have harmful biologic effects that could increase the risk of type 2 diabetes (T2D), but evidence remains uncertain. We aimed to investigate the prospective associations of TFA biomarkers and T2D by conducting an individual participant-level pooled analysis.
We included data from an international consortium of 12 prospective cohorts and nested case-control studies from six nations. TFA biomarkers were measured in blood collected between 1990 and 2008 from 25,126 participants aged ≥18 years without prevalent diabetes. Each cohort conducted de novo harmonized analyses using a prespecified protocol, and findings were pooled using inverse-variance weighted meta-analysis. Heterogeneity was explored by prespecified between-study and within-study characteristics.
During a mean follow-up of 13.5 years, 2,843 cases of incident T2D were identified. In multivariable-adjusted pooled analyses, no significant associations with T2D were identified for trans/trans-18:2, relative risk (RR) 1.09 (95% CI 0.94-1.25); cis/trans-18:2, 0.89 (0.73-1.07); and trans/cis-18:2, 0.87 (0.73-1.03). Trans-16:1n-9, total trans-18:1, and total trans-18:2 were inversely associated with T2D (RR 0.81 [95% CI 0.67-0.99], 0.86 [0.75-0.99], and 0.84 [0.74-0.96], respectively). Findings were not significantly different according to prespecified sources of potential heterogeneity (each P ≥ 0.1).
Circulating individual trans-18:2 TFA biomarkers were not associated with risk of T2D, while trans-16:1n-9, total trans-18:1, and total trans-18:2 were inversely associated. Findings may reflect the influence of mixed TFA sources (industrial vs. natural ruminant), a general decline in TFA exposure due to policy changes during this period, or the relatively limited range of TFA levels.
Details
- Title: Subtitle
- Trans Fatty Acid Biomarkers and Incident Type 2 Diabetes: Pooled Analysis of 12 Prospective Cohort Studies in the Fatty Acids and Outcomes Research Consortium (FORCE)
- Creators
- Heidi T M Lai - Imperial College LondonFumiaki Imamura - MRC Epidemiology UnitAndres V Ardisson Korat - Brigham and Women's HospitalRachel A Murphy - University of British ColumbiaNathan Tintle - Dordt UniversityJulie K Bassett - Cancer Council VictoriaJiaying Chen - Brigham and Women's HospitalJanine Kröger - German Institute of Human NutritionKuo-Liong Chien - National Taiwan UniversityMackenzie Senn - Baylor College of MedicineAlexis C Wood - Baylor College of MedicineNita G Forouhi - MRC Epidemiology UnitMatthias B Schulze - University of PotsdamWilliam S Harris - University of South DakotaRamachandran S Vasan - Boston UniversityFrank Hu - Brigham and Women's HospitalGraham G Giles - Monash UniversityAllison Hodge - Cancer Council VictoriaLuc Djousse - Brigham and Women's HospitalIngeborg A Brouwer - Vrije Universiteit AmsterdamFrank Qian - Harvard UniversityQi Sun - Brigham and Women's HospitalJason H Y Wu - The George Institute for Global HealthMatti Marklund - Tufts UniversityRozenn N Lemaitre - University of WashingtonDavid S Siscovick - The New York Academy of Medicine, New York, NY.Amanda M Fretts - University of WashingtonAladdin H Shadyab - University of California San DiegoJoAnn E Manson - Harvard UniversityBarbara V Howard - Georgetown University Medical CenterJennifer G Robinson - University of IowaRobert B Wallace - University of IowaNick J Wareham - University of CambridgeYii-Der Ida Chen - The Lundquist InstituteJerome I Rotter - The Lundquist InstituteMichael Y Tsai - University of MinnesotaRenata Micha - Tufts UniversityDariush Mozaffarian - Tufts UniversityFatty Acids and Outcomes Research Consortium (FORCE)
- Resource Type
- Journal article
- Publication Details
- Diabetes care, Vol.45(4), pp.854-863
- DOI
- 10.2337/dc21-1756
- PMID
- 35142845
- PMCID
- PMC9114723
- NLM abbreviation
- Diabetes Care
- ISSN
- 1935-5548
- eISSN
- 1935-5548
- Grant note
- R01 HL115189 / NHLBI NIH HHS MC_UU_00006/3 / Medical Research Council T32 CA009001 / NCI NIH HHS MC_UU_00006/1 / Medical Research Council UM1 CA186107 / NCI NIH HHS R01 HL060712 / NHLBI NIH HHS
- Language
- English
- Date published
- 04/01/2022
- Academic Unit
- Epidemiology; Fraternal Order of Eagles Diabetes Research Center; Injury Prevention Research Center; Internal Medicine
- Record Identifier
- 9984364407302771
Metrics
9 Record Views